Morning Movers 03/19: (AMPE) (ABVT) (IPSU) Higher; (CRME) Lower

Cardiome Pharma Corp. (Nasdaq: CRME) 48.2% LOWER; today announced that Merck (NYSE: MRK) has communicated to Cardiome their decision to discontinue further development of the oral formulation of vernakalant. The decision was based on Merck's assessment of the regulatory environment and projected development timeline. Vernakalant oral was being evaluated as maintenance therapy for the long term prevention of atrial fibrillation recurrence.

Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE) 47.6% HIGHER; today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina™ trial for diabetic macular edema. Click here to see the full report.

AboveNet, Inc. (NYSE: ABVT) 13.4% HIGHER; Zayo Group, LLC and AboveNet today announced that their boards of directors have approved a definitive agreement under which Zayo will acquire AboveNet for approximately $2.2 billion.

Imperial Sugar (Nasdaq: IPSU) 9.7% HIGHER; the US has approved the deal between Imperial Sugar and Arlon Food. Bloomberg headlines suggest the FTC statement does not specify on which transaction has been approved.

DHT Holdings (NYSE: DHT) 9% HIGHER; Baltic Dry Index continuing higher this week, now around 879. Shares surged 21 percent last week.

Gastar Exploration (AMEX: GST) 8.8% HIGHER; continuing higher following an 8 percent move higher on Friday to push the stock above $3. Volume is very heavy this morning.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
• Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises